Ken Griffin started to build up the position in Signify Health in Q1 2021 and continued to invest until Q2 2022. Since then they sold 3.48 Million shares. The investor completely sold their stake between Q3 2022 and Q1 2023.
Avg closing price
Price range
Sold -124 Thousand shares
Q1 2023
Avg closing price
$28.79
Price range
$28.24
-
$30.49
Sold 83.2% shares (-616 Thousand shares)
Q4 2022
Avg closing price
$28.86
Price range
$28.35
-
$29.50
Sold 78.8% shares (-2.74 Million shares)
Q3 2022
Avg closing price
$23.03
Price range
$14.86
-
$29.32
Increased shares by 11.3% (+353 Thousand shares)
Q2 2022
Avg closing price
$14.08
Price range
$11.19
-
$18.50
Increased shares by 220.6% (+2.15 Million shares)
Q1 2022
Avg closing price
$14.34
Price range
$11.42
-
$18.39
Increased shares by 138.1% (+566 Thousand shares)
Q4 2021
Avg closing price
$15.48
Price range
$12.98
-
$18.05
Increased shares by 105.3% (+210 Thousand shares)
Q3 2021
Avg closing price
$25.72
Price range
$17.87
-
$30.50
Increased shares by 780.0% (+177 Thousand shares)
Q2 2021